Clinical Trials in China / NCT06967207
Recruiting
Observational
Electrical Impedance Tomography-Based Prognostic Model for ARDS
NCT06967207 · tracked via the Priya Life Science China tracker
Condition(s) studied
Acute Respiratory Distress Syndrome (ARDS)Ventilator-induced Lung Injury
Investigational drug(s) / intervention(s)
Not applicable- observational study
Not applicable- observational study: Not applicable- observational study
Study summary
This multicenter, prospective, observational study aims to develop and validate an EIT-based prognostic model for ARDS. By focusing on the pathophysiological characteristics of ARDS and the causes of ventilator-induced lung injury, the investigators intend to establish a prognostic model that reveals lung injury and heterogeneity, enabling risk stratification and guiding individualized treatment.
Eligibility
Inclusion Criteria:
1. Meet the new 2023 ARDS global definition;
2. Age 18-80 years
Exclusion Criteria:
1. Expected death within 24 hours of screening;
2. Metastatic cancer (active malignancy with distant metastases);
3. Severe psychiatric disorders;
4. Pregnancy or postpartum status;
5. Pneumothorax or moderate to large pleural effusion without adequate drainage;
6. Chronic respiratory failure;
7. Patients with pulmonary embolism or pulmonary hypertension;
8. Heart failure patients: EF \<50% or NYHA class III or IV;
9. Patient/family refusal to participate;
10. Participation in another interventional trial within 3 months prior to enrollment
Primary outcome measure(s)
- 28-day mortality rate — From date of study enrollment (Day 0) until Day 28
Trial sites (4)
| Facility | City | Region | Status |
|---|---|---|---|
| Department of Critical Care Medicine, Guangdong Provincial People's Hospital | Guangzhou | Guangdong | Recruiting |
| Department of Critical Care Medicine, Renmin Hospital of Wuhan University | Wuhan | Hubei | Recruiting |
| Department of Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, China Department of | Wuhan | Hubei | Recruiting |
| Department of Emergency, Zhongshan Hospital, Fudan University | Shanghai | Shanghai Municipality | Recruiting |
More XiaoJing Zou,MD trials in China
Other trials for the same condition
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06967207 on ClinicalTrials.gov ↗ ← All trials in China